IGFBP2 Drives Regulatory T Cell Differentiation through STAT3/IDO Signaling Pathway in Pancreatic Cancer
Open Access
- 3 December 2022
- journal article
- research article
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 12 (12) , 2005
Abstract
Pancreatic ductal adenocarcinoma (PDAC) represents one of the deadliest malignancies. Elevated regulatory T cell (Treg) infiltration has a potent immunosuppressive function in tumor biology, which contributes to low survival in PDAC. Nonetheless, the crosstalk between malignant cells and tumor-infiltrating Tregs in PDAC is not well understood. Here, clinical data demonstrates that the insulin-like growth factor binding protein 2 (IGFBP2) is associated with Treg accumulation in the microenvironment of PDAC in humans. Additionally, IGFBP2 increases Treg infiltration in the tumor microenvironment and promotes disease progression in mouse PDAC. Bioinformatic analysis and mechanistic assessment reveals IGFBP2 upregulated indoleamine 2, 3-dioxygenase (IDO) by activating signal transducer and activator of transcription 3 (STAT3) signaling in PDAC cells, thus inducing Treg differentiation and an immunosuppressive tumor microenvironment. These findings provide mechanistic insights into an important molecular pathway that promotes an immunosuppressive microenvironment, which suggests the IGFBP2 axis as a potential target for improved immune response in PDAC.Keywords
Funding Information
- Tianjin Health Science and Technology Project (TJWJ2022MS002, 81702410, 17JCQNJC11100)
- National Natural Science Foundation of China (TJWJ2022MS002, 81702410, 17JCQNJC11100)
- Natural Science Foundation of Tianjin (TJWJ2022MS002, 81702410, 17JCQNJC11100)
This publication has 37 references indexed in Scilit:
- Immune heterogeneity and clinicopathologic characterization of IGFBP2 in 2447 glioma samplesOncoImmunology, 2018
- The role of STAT3 in leading the crosstalk between human cancers and the immune systemCancer Letters, 2018
- Use of PD-1 Targeting, Macrophage Infiltration, and IDO Pathway Activation in SarcomasJAMA Oncology, 2018
- The Immune-microenvironment Confers Chemoresistance of Colorectal Cancer through Macrophage-Derived IL6Clinical Cancer Research, 2017
- IGFBP2 Activates the NF-κB Pathway to Drive Epithelial–Mesenchymal Transition and Invasive Character in Pancreatic Ductal AdenocarcinomaCancer Research, 2016
- Two-dimensional culture of human pancreatic adenocarcinoma cells results in an irreversible transition from epithelial to mesenchymal phenotypeLaboratory Investigation, 2014
- NGAL Expression Is Elevated in Both Colorectal Adenoma–Carcinoma Sequence and Cancer Progression and Enhances Tumorigenesis in Xenograft Mouse ModelsClinical Cancer Research, 2011
- Guidelines for the welfare and use of animals in cancer researchBritish Journal of Cancer, 2010
- Involvement of insulin-like growth factor binding protein-2 in activated microglia as assessed in post mortem human brainNeuroscience Letters, 2004
- In VivoExpression of Insulin-Like Growth Factor-Binding Protein-2 in Human Gliomas Increases with the Tumor Grade1Endocrinology, 2001